Final results of weekly paclitaxel and carboplatin plus...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Final results of weekly paclitaxel and carboplatin plus bevacizumab as first-line treatment of triple-negative breast cancer. A multicenter phase I-II trial by the Hellenic Oncology Research Group

Nikolaou, M., Saloustros, E., Polyzos, A., Christophyllakis, C., Kentepozidis, N., Vamvakas, L., Kalbakis, K., Agelaki, S., Georgoulias, V., Mavroudis, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw365.21
Date:
October, 2016
File:
PDF, 36 KB
english, 2016
Conversion to is in progress
Conversion to is failed